MedTrace Logo

A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men

NCT05742919 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-06-11

No results posted yet for this study

Summary

This study looks at how a new study medicine called NNC0194-0499 behaves in the body of Chinese men. Three different dose levels will be tested. Participant will get only one of the three different dose levels of NNC0194-0499. Which dose participant will get will be decided by chance. NNC0194-0499 is a medicine under clinical investigation. It means that the medicine has not yet been approved by the health authorities. Participant will get 1 or 2 injections of the study medicine. It will be injected with a needle into a skin fold on stomach. The study will last for a maximum of 64 days. Participant will not be able to take part in the study if the study doctor considers there is a risk for participant's health.

Conditions

  • Non-alcoholic Fatty Liver Disease

Interventions

DRUG

NNC0194-0499

Participants will receive a single s.c. dose of 12 mg NNC0194-0499 on Day 1.

DRUG

NNC0194-0499

Participants will receive a single s.c. dose of 30 mg NNC0194-0499 on Day 1.

DRUG

NC0194-0499

Participants will receive a single s.c. dose of 96 mg NNC0194-0499 on Day 1.

Sponsors & Collaborators

Principal Investigators

  • Clinical Transparency dept. 2834 · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-16
Primary Completion
2023-06-13
Completion
2023-06-13

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05742919 on ClinicalTrials.gov